Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'. This signals that the trial's results have been submitted for posting or review.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a new site revision label 'Revision: v3.3.2' and removal of 'Revision: v3.2.0', a routine maintenance/version-tracking change with no impact on study data, eligibility criteria, outcomes, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice was removed from the page. This change does not affect the study details, eligibility criteria, or contacts.SummaryDifference0.4%

- Check42 days agoChange DetectedMinor administrative edits and timestamp updates with no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.